Marek, A; Stern, M; Chalandon, Y; Ansari, M; Ozsahin, H; Güngör, T; Gerber, B; Kühne, T; Passweg, J R; Gratwohl, A; Tichelli, A; Seger, R; Schanz, U; Halter, J; Stussi, G (2014). The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplantation, 49(1):55-61.
Agyeman, P; Aebi, C; Hirt, A; Niggli, F K; Nadal, D; Simon, A; Ozsahin, H; Kontny, U; Kühne, T; Beck Popovic, M; Leibundgut, K; Bodmer, N; Ammann, R A (2011). Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. The Pediatric Infectious Disease Journal, 30(7):e114-e119.
Andreou, D; Bielack, S S; Carrle, D; Kevric, M; Kotz, R; Winkelmann, W; Jundt, G; Werner, M; Fehlberg, S; Kager, L; Kühne, T; Lang, S; Dominkus, M; Exner, G U; Hardes, J; Hillmann, A; Ewerbeck, V; Heise, U; Reichardt, P; Tunn, P-U (2011). The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Annals of Oncology, 22(5):1228-1235.
Ammann, R A; Bodmer, N; Hirt, A; Niggli, F K; Nadal, D; Simon, A; Ozsahin, H; Kontny, U; Kühne, T; Beck Popovic, M; Ridolfi Lüthy, A; Aebi, C (2010). Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. Journal of Clinical Oncology, 28(12):2008-2014.
Wehrli, L A; Braun, J; Buetti, L N; Hagleitner, N; Hengartner, H; Kühne, T; Lüer, S; Ozsahin, H; Beck Popovic, M; Niggli, F K; Betts, D R; Bourquin, J P (2009). Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 189(1):29-36.